View ValuationGivaudan 향후 성장Future 기준 점검 1/6Givaudan (는) 각각 연간 5.4% 및 3.9% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 5.1% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 22.3% 로 예상됩니다.핵심 정보5.4%이익 성장률5.07%EPS 성장률Chemicals 이익 성장62.1%매출 성장률3.9%향후 자기자본이익률22.27%애널리스트 커버리지Good마지막 업데이트13 May 2026최근 향후 성장 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • 7hGivaudan SA, Annual General Meeting, Mar 24, 2027Givaudan SA, Annual General Meeting, Mar 24, 2027.공시 • Apr 15Givaudan SA to Report Fiscal Year 2026 Results on Jan 27, 2027Givaudan SA announced that they will report fiscal year 2026 results on Jan 27, 2027공시 • Apr 08Givaudan Active Beauty Showcases AI-Powered Ingredient Innovations With Haut.AI At In-Cosmetics GlobalGivaudan Active Beauty, the reference in high-precision beauty ingredients, has partnered with Haut.AI, to spotlight a new era of AI-driven ingredient innovation. At this year's in-cosmetics Global 2026 (April 14–16, Paris), Givaudan Active Beauty will be the first to showcase its latest active ingredients through immersive GenAI-powered activations that allow attendees to virtually "experience" their benefits firsthand via personalized, photorealistic simulations powered by Haut.AI's SkinGPT technology. As the beauty industry accelerates toward measurable efficacy, personalization, and clinically validated claims, artificial intelligence is becoming a critical bridge between laboratory science and visible consumer outcomes. In this spirit, Givaudan has selected Haut.AI's scientifically grounded skin analysis and SkinGPT simulation technologies to deliver an interactive, ingredient-focused experience at one of the industry's most influential global stages. Building on this collaboration, Givaudan Active Beauty's latest active ingredient will serve as the foundation for an interactive SkinGPT-powered virtual try-on experience at the Givaudan booth in Paris. By taking a selfie of their own face, attendees will be able to digitally "apply" the ingredient and visualize how it may influence visible skin parameters over time through a photorealistic simulation. Meanwhile they will be able to experience an AI Skin Expert analyzing their skin and delivering personalized recommendations of high precision beauty ingredients. Givaudan Active Beauty's latest breakthrough, PrimalHyal™ NeuroYouth targets the newly identified Neuro Skin Ageing pathway, supporting nerve fiber regeneration and neuronal function. By integrating AI-powered validation and immersive simulations at booth at in-cosmetics Global, the company will share this innovation in a way that allows both customers and consumers to truly experience it. Visitors to the Givaudan Active Beauty booth will be invited to engage with two AI-powered experiences: SkinGPT: At in-cosmetics Global 2026, Givaudan will unveil its latest active ingredient in an immersive experience. For the first time, attendees will be able to literally try on the formulation on their own skin through a live facial scan, instantly visualizing how it may transform visible skin parameters over time. AI Skin Expert: An on-site skin assessment providing participants with comprehensive skin insights and active ingredient recommendations aligned with their unique skin characteristics.공시 • Feb 23Givaudan SA, Annual General Meeting, Mar 19, 2026Givaudan SA, Annual General Meeting, Mar 19, 2026, at 10:30 W. Europe Standard Time.공시 • Jan 30Givaudan SA announces Annual dividend, payable on March 25, 2026Givaudan SA announced Annual dividend of CHF 72.0000 per share payable on March 25, 2026, ex-date on March 23, 2026 and record date on March 24, 2026.공시 • Nov 08Givaudan SA to Report First Half, 2026 Results on Jul 23, 2026Givaudan SA announced that they will report first half, 2026 results on Jul 23, 2026공시 • Aug 28Givaudan SA Announces CEO ChangesGivaudan SA announced that Christian Stammkoetter would succeed its Chief Executive Officer, Gilles Andrier, who will retire after 20 years at the helm of the company. Stammkoetter-- who is currently president of Asia, Middle East and Africa at the French food company Danone--would take over the role effective March 1. Andrier will be proposed for election as chairman at the 2026 annual general meeting as Calvin Grieder is set to step down from the board after 12 years.공시 • Apr 10Givaudan SA to Report Fiscal Year 2025 Results on Jan 29, 2026Givaudan SA announced that they will report fiscal year 2025 results on Jan 29, 2026공시 • Feb 24Givaudan SA, Annual General Meeting, Mar 20, 2025Givaudan SA, Annual General Meeting, Mar 20, 2025, at 10:30 W. Europe Standard Time.공시 • Aug 24Givaudan SA to Report Q3, 2025 Results on Oct 14, 2025Givaudan SA announced that they will report Q3, 2025 results at 7:00 AM, Central European Standard Time on Oct 14, 2025공시 • Aug 23Givaudan SA to Report First Half, 2025 Results on Jul 22, 2025Givaudan SA announced that they will report first half, 2025 results on Jul 22, 2025공시 • Jul 02Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a.Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a. on July 1, 2024. Givaudan plans to finance this acquisition through debt.Givaudan SA (SWX:GIVN) completed the acquisition of remaining 75% stake in B. Kolormakeup & Skincare S.p.a.공시 • Apr 12Givaudan SA to Report Fiscal Year 2024 Results on Jan 24, 2025Givaudan SA announced that they will report fiscal year 2024 results on Jan 24, 2025Upcoming Dividend • Mar 18Upcoming dividend of CHF68.00 per shareEligible shareholders must have bought the stock before 25 March 2024. Payment date: 27 March 2024. Payout ratio is a comfortable 70% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Mexican dividend payers (6.3%). Lower than average of industry peers (10%).공시 • Feb 08Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) .Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) on February 6, 2024. The acquisition will be 100% funded by the External Growth Credit Line contracted by Groupe Berkem. The transaction is expected to be closed on May 31, 2024. Oghma Partners acted as exclusive corporate finance advisor to Givaudan S.A.공시 • Oct 19Givaudan SA to Report First Half, 2024 Results on Jul 23, 2024Givaudan SA announced that they will report first half, 2024 results on Jul 23, 2024공시 • Oct 17Givaudan SA, Annual General Meeting, Mar 21, 2024Givaudan SA, Annual General Meeting, Mar 21, 2024.Reported Earnings • Jan 31Full year 2022 earnings released: EPS: CHF92.83 (vs CHF89.03 in FY 2021)Full year 2022 results: EPS: CHF92.83 (up from CHF89.03 in FY 2021). Revenue: CHF7.12b (up 6.5% from FY 2021). Net income: CHF856.0m (up 4.3% from FY 2021). Profit margin: 12% (in line with FY 2021). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South America are expected to remain flat.공시 • Jan 25Givaudan SA to Report Fiscal Year 2023 Results on Jan 25, 2024Givaudan SA announced that they will report fiscal year 2023 results on Jan 25, 2024공시 • Oct 12Givaudan SA to Report Q2, 2022 Results on Jul 20, 2023Givaudan SA announced that they will report Q2, 2022 results at 7:00 AM, Central European Standard Time on Jul 20, 2023공시 • Jul 22Givaudan SA to Report Fiscal Year 2022 Results on Jan 25, 2023Givaudan SA announced that they will report fiscal year 2022 results on Jan 25, 2023공시 • Feb 16Givaudan SA, Annual General Meeting, Mar 23, 2023Givaudan SA, Annual General Meeting, Mar 23, 2023.이익 및 매출 성장 예측BMV:GIVN N - 애널리스트 향후 추정치 및 과거 재무 데이터 (CHF Millions)날짜매출이익자유현금흐름영업현금흐름평균 애널리스트 수12/31/20288,2481,2471,1831,6771312/31/20277,8901,1711,1511,5951812/31/20267,5381,0641,0591,5151712/31/20257,4721,0711,2111,512N/A9/30/20257,5061,0831,1631,479N/A6/30/20257,5391,0941,1141,446N/A3/31/20257,4761,0921,2231,536N/A12/31/20247,4121,0901,3321,625N/A9/30/20247,2651,0611,3491,543N/A6/30/20247,1171,0321,3661,460N/A3/31/20247,0169631,2321,417N/A12/31/20236,9158931,0981,373N/A9/30/20236,9588799011,265N/A6/30/20237,0008657041,157N/A3/31/20237,0598616741,053N/A12/31/20227,117856644948N/A9/30/20227,040818676976N/A6/30/20226,9637807081,004N/A3/31/20226,8248018701,146N/A12/31/20216,6848211,0321,288N/A9/30/20216,5798161,0191,252N/A6/30/20216,4748111,0061,215N/A3/31/20216,3987779851,202N/A12/31/20206,3227439641,189N/A9/30/20206,3267399571,222N/A6/30/20206,3307359491,254N/A3/31/20206,2677198831,195N/A12/31/20196,2037028161,136N/A9/30/20196,075687N/A1,027N/A6/30/20195,947672N/A918N/A3/31/20195,737668N/A917N/A12/31/20185,527663N/A916N/A9/30/20185,385685N/A889N/A6/30/20185,242707N/A861N/A3/31/20185,147714N/A861N/A12/31/20175,051720N/A861N/A9/30/20174,932690N/A849N/A6/30/20174,812660N/A837N/A3/31/20174,738652N/A821N/A12/31/20164,663644N/A805N/A9/30/20164,605648N/A808N/A6/30/20164,546651N/A811N/A3/31/20164,471638N/A863N/A12/31/20154,396625N/A915N/A9/30/20154,397613N/A922N/A6/30/20154,397600N/A929N/A더 보기애널리스트 향후 성장 전망수입 대 저축률: GIVN N 의 연간 예상 수익 증가율(5.4%)이 saving rate(9%) 미만입니다.수익 vs 시장: GIVN N 의 연간 수익(5.4%)이 MX 시장(9.1%)보다 느리게 성장할 것으로 예상됩니다.고성장 수익: GIVN N 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.수익 대 시장: GIVN N 의 수익(연간 3.9%)이 MX 시장(연간 6.2%)보다 느리게 성장할 것으로 예상됩니다.고성장 매출: GIVN N 의 수익(연간 3.9%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.주당순이익 성장 예측향후 자기자본이익률미래 ROE: GIVN N의 자본 수익률은 3년 후 22.3%로 높을 것으로 예상됩니다.성장 기업 찾아보기7D1Y7D1Y7D1YMaterials 산업의 고성장 기업.View Past Performance기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 07:53종가2026/03/13 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Givaudan SA는 37명의 분석가가 다루고 있습니다. 이 중 18명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Konstantin WiechertBaader Helvea Equity ResearchVolker BosseBaader Helvea Equity ResearchJames KnightBarclays34명의 분석가 더 보기
공시 • 7hGivaudan SA, Annual General Meeting, Mar 24, 2027Givaudan SA, Annual General Meeting, Mar 24, 2027.
공시 • Apr 15Givaudan SA to Report Fiscal Year 2026 Results on Jan 27, 2027Givaudan SA announced that they will report fiscal year 2026 results on Jan 27, 2027
공시 • Apr 08Givaudan Active Beauty Showcases AI-Powered Ingredient Innovations With Haut.AI At In-Cosmetics GlobalGivaudan Active Beauty, the reference in high-precision beauty ingredients, has partnered with Haut.AI, to spotlight a new era of AI-driven ingredient innovation. At this year's in-cosmetics Global 2026 (April 14–16, Paris), Givaudan Active Beauty will be the first to showcase its latest active ingredients through immersive GenAI-powered activations that allow attendees to virtually "experience" their benefits firsthand via personalized, photorealistic simulations powered by Haut.AI's SkinGPT technology. As the beauty industry accelerates toward measurable efficacy, personalization, and clinically validated claims, artificial intelligence is becoming a critical bridge between laboratory science and visible consumer outcomes. In this spirit, Givaudan has selected Haut.AI's scientifically grounded skin analysis and SkinGPT simulation technologies to deliver an interactive, ingredient-focused experience at one of the industry's most influential global stages. Building on this collaboration, Givaudan Active Beauty's latest active ingredient will serve as the foundation for an interactive SkinGPT-powered virtual try-on experience at the Givaudan booth in Paris. By taking a selfie of their own face, attendees will be able to digitally "apply" the ingredient and visualize how it may influence visible skin parameters over time through a photorealistic simulation. Meanwhile they will be able to experience an AI Skin Expert analyzing their skin and delivering personalized recommendations of high precision beauty ingredients. Givaudan Active Beauty's latest breakthrough, PrimalHyal™ NeuroYouth targets the newly identified Neuro Skin Ageing pathway, supporting nerve fiber regeneration and neuronal function. By integrating AI-powered validation and immersive simulations at booth at in-cosmetics Global, the company will share this innovation in a way that allows both customers and consumers to truly experience it. Visitors to the Givaudan Active Beauty booth will be invited to engage with two AI-powered experiences: SkinGPT: At in-cosmetics Global 2026, Givaudan will unveil its latest active ingredient in an immersive experience. For the first time, attendees will be able to literally try on the formulation on their own skin through a live facial scan, instantly visualizing how it may transform visible skin parameters over time. AI Skin Expert: An on-site skin assessment providing participants with comprehensive skin insights and active ingredient recommendations aligned with their unique skin characteristics.
공시 • Feb 23Givaudan SA, Annual General Meeting, Mar 19, 2026Givaudan SA, Annual General Meeting, Mar 19, 2026, at 10:30 W. Europe Standard Time.
공시 • Jan 30Givaudan SA announces Annual dividend, payable on March 25, 2026Givaudan SA announced Annual dividend of CHF 72.0000 per share payable on March 25, 2026, ex-date on March 23, 2026 and record date on March 24, 2026.
공시 • Nov 08Givaudan SA to Report First Half, 2026 Results on Jul 23, 2026Givaudan SA announced that they will report first half, 2026 results on Jul 23, 2026
공시 • Aug 28Givaudan SA Announces CEO ChangesGivaudan SA announced that Christian Stammkoetter would succeed its Chief Executive Officer, Gilles Andrier, who will retire after 20 years at the helm of the company. Stammkoetter-- who is currently president of Asia, Middle East and Africa at the French food company Danone--would take over the role effective March 1. Andrier will be proposed for election as chairman at the 2026 annual general meeting as Calvin Grieder is set to step down from the board after 12 years.
공시 • Apr 10Givaudan SA to Report Fiscal Year 2025 Results on Jan 29, 2026Givaudan SA announced that they will report fiscal year 2025 results on Jan 29, 2026
공시 • Feb 24Givaudan SA, Annual General Meeting, Mar 20, 2025Givaudan SA, Annual General Meeting, Mar 20, 2025, at 10:30 W. Europe Standard Time.
공시 • Aug 24Givaudan SA to Report Q3, 2025 Results on Oct 14, 2025Givaudan SA announced that they will report Q3, 2025 results at 7:00 AM, Central European Standard Time on Oct 14, 2025
공시 • Aug 23Givaudan SA to Report First Half, 2025 Results on Jul 22, 2025Givaudan SA announced that they will report first half, 2025 results on Jul 22, 2025
공시 • Jul 02Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a.Givaudan SA (SWX:GIVN) acquired remaining 75% stake in B. Kolormakeup & Skincare S.p.a. on July 1, 2024. Givaudan plans to finance this acquisition through debt.Givaudan SA (SWX:GIVN) completed the acquisition of remaining 75% stake in B. Kolormakeup & Skincare S.p.a.
공시 • Apr 12Givaudan SA to Report Fiscal Year 2024 Results on Jan 24, 2025Givaudan SA announced that they will report fiscal year 2024 results on Jan 24, 2025
Upcoming Dividend • Mar 18Upcoming dividend of CHF68.00 per shareEligible shareholders must have bought the stock before 25 March 2024. Payment date: 27 March 2024. Payout ratio is a comfortable 70% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of Mexican dividend payers (6.3%). Lower than average of industry peers (10%).
공시 • Feb 08Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) .Groupe Berkem Société anonyme (ENXTPA:ALKEM) signed a definitive agreement to acquire Naturex Iberian Partners, S.L.U from Givaudan SA (SWX:GIVN) on February 6, 2024. The acquisition will be 100% funded by the External Growth Credit Line contracted by Groupe Berkem. The transaction is expected to be closed on May 31, 2024. Oghma Partners acted as exclusive corporate finance advisor to Givaudan S.A.
공시 • Oct 19Givaudan SA to Report First Half, 2024 Results on Jul 23, 2024Givaudan SA announced that they will report first half, 2024 results on Jul 23, 2024
공시 • Oct 17Givaudan SA, Annual General Meeting, Mar 21, 2024Givaudan SA, Annual General Meeting, Mar 21, 2024.
Reported Earnings • Jan 31Full year 2022 earnings released: EPS: CHF92.83 (vs CHF89.03 in FY 2021)Full year 2022 results: EPS: CHF92.83 (up from CHF89.03 in FY 2021). Revenue: CHF7.12b (up 6.5% from FY 2021). Net income: CHF856.0m (up 4.3% from FY 2021). Profit margin: 12% (in line with FY 2021). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, while revenues in the Chemicals industry in South America are expected to remain flat.
공시 • Jan 25Givaudan SA to Report Fiscal Year 2023 Results on Jan 25, 2024Givaudan SA announced that they will report fiscal year 2023 results on Jan 25, 2024
공시 • Oct 12Givaudan SA to Report Q2, 2022 Results on Jul 20, 2023Givaudan SA announced that they will report Q2, 2022 results at 7:00 AM, Central European Standard Time on Jul 20, 2023
공시 • Jul 22Givaudan SA to Report Fiscal Year 2022 Results on Jan 25, 2023Givaudan SA announced that they will report fiscal year 2022 results on Jan 25, 2023
공시 • Feb 16Givaudan SA, Annual General Meeting, Mar 23, 2023Givaudan SA, Annual General Meeting, Mar 23, 2023.